The stock of MOCON, Inc. (NASDAQ:MOCO) gapped up by $7.4 today and has $32.08 target or 8.00% above today’s $29.70 share price. The 6 months technical chart setup indicates low risk for the $169.58M company. The gap was reported on Apr, 17 by Barchart.com. If the $32.08 price target is reached, the company will be worth $13.57M more. About 918,359 shares traded or 6233.07% up from the average. MOCON, Inc. (NASDAQ:MOCO) has risen 36.16% since September 8, 2016 and is uptrending. It has outperformed by 29.39% the S&P500.
Allscripts Healthcare Solutions, Inc. delivers information technology (IT) solutions and services to help healthcare organizations. The company has market cap of $2.13 billion. The Firm operates through three divisions: Clinical and Financial Solutions, Population Health, and Netsmart. It currently has negative earnings. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Analysts await MOCON, Inc. (NASDAQ:MOCO) to report earnings on May, 4.
MOCON, Inc. designs, manufactures, markets and services products, and provides consulting services, primarily in the test and measurement, analytical instrument and services markets. The company has market cap of $169.58 million. The Company’s divisions are Permeation Products and Services , Package Testing Products and Services (Package Testing), and Industrial Analyzer Products and Services and Other (Industrial Analyzers and Other). It has a 34.75 P/E ratio. The Company’s products include instruments that detect, measure and monitor gases and other chemical compounds.
Investors sentiment decreased to 1.14 in Q4 2016. Its down 0.74, from 1.88 in 2016Q3. It dived, as 5 investors sold MOCON, Inc. shares while 9 reduced holdings. 3 funds opened positions while 13 raised stakes. 2.35 million shares or 7.95% more from 2.18 million shares in 2016Q3 were reported. 75,198 were reported by Gamco Et Al. Teton Advisors reported 411,930 shares. Geode Mngmt Ltd Limited Liability Company has invested 0% of its portfolio in MOCON, Inc. (NASDAQ:MOCO). Morgan Stanley has 0% invested in MOCON, Inc. (NASDAQ:MOCO). Acadian Asset Mgmt Ltd Limited Liability Company holds 0% or 1,191 shares. Moreover, National Bank Of Ny Mellon has 0% invested in MOCON, Inc. (NASDAQ:MOCO) for 29,995 shares. Renaissance Technologies Ltd reported 0% of its portfolio in MOCON, Inc. (NASDAQ:MOCO). First Manhattan Co holds 0% of its portfolio in MOCON, Inc. (NASDAQ:MOCO) for 21,647 shares. Blackrock Ltd Com reported 952 shares or 0% of all its holdings. Manufacturers Life Insurance Com The invested in 396 shares or 0% of the stock. 3,400 were reported by Us Savings Bank De. Yacktman Asset L P owns 29,000 shares for 0.01% of their portfolio. Blackrock Fund Advsrs holds 14,990 shares. Mairs And Power stated it has 152,590 shares or 0.04% of all its holdings. Bard Associate Incorporated owns 85,462 shares or 0.77% of their US portfolio.
About 907,772 shares traded. Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has declined 5.85% since September 8, 2016 and is downtrending. It has underperformed by 12.62% the S&P500.
Ratings analysis reveals 50% of Allscripts-Misys Healthcare’s analysts are positive. Out of 20 Wall Street analysts rating Allscripts-Misys Healthcare, 10 give it “Buy”, 1 “Sell” rating, while 9 recommend “Hold”. The lowest target is $12 while the high is $19.0. The stock’s average target of $15.37 is 29.05% above today’s ($11.91) share price. MDRX was included in 31 notes of analysts from August 5, 2015. RBC Capital Markets maintained Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) rating on Wednesday, August 5. RBC Capital Markets has “Sector Perform” rating and $14 target. The company was maintained on Wednesday, August 5 by Topeka Capital Markets. Morgan Stanley downgraded the stock to “Underweight” rating in Tuesday, December 13 report. The rating was reinitiated by Jefferies with “Buy” on Friday, October 16. Morgan Stanley upgraded the shares of MDRX in report on Wednesday, March 30 to “Overweight” rating. The firm earned “Hold” rating on Thursday, November 10 by Deutsche Bank. The rating was upgraded by Wells Fargo on Monday, March 27 to “Outperform”. The firm has “Hold” rating given on Tuesday, January 5 by Topeka Capital Markets. Maxim Group maintained the shares of MDRX in report on Tuesday, January 10 with “Buy” rating. Raymond James downgraded the shares of MDRX in report on Monday, January 4 to “Mkt Perform” rating.
Since January 1, 0001, it had 0 insider purchases, and 1 insider sale for $174,467 activity.
Analysts await Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) to report earnings on May, 4. They expect $0.10 earnings per share, up 11.11% or $0.01 from last year’s $0.09 per share. MDRX’s profit will be $17.88 million for 29.78 P/E if the $0.10 EPS becomes a reality. After $0.10 actual earnings per share reported by Allscripts Healthcare Solutions Inc for the previous quarter, Wall Street now forecasts 0.00% EPS growth.
Glenhill Advisors Llc holds 5.54% of its portfolio in Allscripts Healthcare Solutions Inc for 7.66 million shares. Blue Harbour Group L.P. owns 9.31 million shares or 3.18% of their US portfolio. Moreover, Paradigm Capital Management Inc Ny has 1.97% invested in the company for 1.99 million shares. The New York-based Adirondack Research & Management Inc. has invested 1.93% in the stock. Broadview Advisors Llc, a Wisconsin-based fund reported 1.01 million shares.
